Order from two customers in Belgium for C-RAD systems

C-RAD has secured an order for a Catalyst HD™, a Catalyst™ system and a Sentinel 4DCT™ system for two radiation therapy centers in Belgium. The order has a total value of 6.1 MSEK.

The Catalyst HD™ and Catalyst will be delivered with the complete software configuration containing modules for Respiratory Gating, Patient Setup and Positioning, and Motion Monitoring, as well as interfaces to Varian and Elekta linear accelerators and the respective CT imaging modality. The customers also selected C-RAD’s unique audio-visual couching functionality, which supports an interactive gating mode.

Delivery and installation are expected to start in September 2016.

Sales and marketing for the C-RAD products in Belgium and the Netherlands is carried out by the Dutch company AEP International B.V. AEP International has more than 35 years of experience marketing and selling high-quality linear accelerator components, as well as representing many renowned RT brands in the Benelux area.

The Catalyst HD™ and Sentinel™ systems enable the high-end treatment techniques that are increasingly common within radiation therapy. With this dual solution, C-RAD supports the whole 4D treatment chain from imaging to treatment delivery. Respiratory gated treatments are frequently used when the target volume is close to cardiac tissue, or for special treatments in which the tumor position depends on the respiratory cycle.

“We are very excited to bring the first installations of the C-RAD Sentinel and Catalyst products to Belgium,” says Edwin Molenaar, Product Group Manager at AEP International. “We are convinced that C-RAD products help clinics improve their treatment accuracy and offer workflow optimization, which both benefit the patient. We look forward to increasing the accessibility of these advanced treatment options in the Benelux area.”

“I am very pleased to announce this orders and to welcome the two radiation therapy clinics in Belgium to our family of new customers,” says Tim Thurn, CEO of C-RAD. “The decision to purchase C-RAD was taken after a thorough analysis of the C-RAD solution and the similar product from a competitor. The customer’s decision underlines the strength of the C-RAD product and confirms our position as the leading vendor of surface tracking solutions for radiation therapy.  

About C-RAD

C-RAD develops innovative solutions for use in advanced radiation therapy. The C-RAD group offers products and solutions for patient positioning, tumor localization and radiation treatment systems. End users are radiation therapy clinics worldwide. All product development is conducted in three fully owned subsidiaries: C-RAD Positioning AB, C-RAD Imaging AB and C-RAD Innovation AB, all of which are located in Uppsala, Sweden. Employees currently number 45. C-RAD’s business originates from research and development at Karolinska Institutet in Solna, Sweden. Sales of the company’s first product, the C-RAD Sentinel^TM, started in 2007. Cooperation agreements have been signed with Elekta (Sweden), Varian (USA) and IBA (Belgium). C-RAD is represented by distributors specialized in radiation therapy on major markets. C-RAD has established three companies for direct sales: C-RAD Inc. in the US, C-RAD GmbH in Germany and C-RAD WOFE in China. Cyrpa International SPRL, a Franco-Belgian laser company, is a wholly owned subsidiary whose operations are integrated. C-RAD AB is listed on NASDAQ Stockholm.

For more information on C-RAD, please visit www.c-rad.com

For further information:

Tim Thurn, CEO C-RAD AB, Phone +46-18-666930, Email investors@c-rad.com

The above information is price-sensitive and must therefore be disclosed under the Securities Market Act (2007:528).